Gold
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
NewBridge pharmaceuticals is a regional specialty company providing a one-stop-solution to pharmaceuticals, biological, genomics and other innovative healthcare companies. Our focus is on in-licensing and commercializing FDA and EMA/European approved innovative therapeutics and diagnostics that address unmet medical needs of diseases with high prevalence within the emerging markets of the AfMET region (Africa, Middle East & Turkey).